International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

Injecting Drug Users Retention in Needle-Exchange Program and its Determinants in Iran Prisons

Mohammad Shahbazi 1 , Marzieh Farnia 2 , Ghobad Moradi 3 , 4 , Mohammadreza Karamati 5 , Fatemeh Paknazar 6 and Majid Mirmohammad Khani 7 , 8 , *
Authors Information
1 United Nations Development Program, Prisons Organization, Tehran, IR Iran
2 Health and Treatment Office of Iranian Prisons Organization, Tehran, IR Iran
3 Social Determinant of Health Research Center, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
4 Epidemiology and Biostatistics Department, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
5 Department of Surgery, Tehran University of Medical Sciences, Tehran, IR Iran
6 Department of Epidemiology and Biostatistics, School of Public Health , International Campus, Tehran University of Medical Sciences, Tehran, IR Iran
7 Research Center for Social Determinants of Health, Semnan University of Medical Sciences, Semnan, IR Iran
8 Community Medicine Department, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, IR Iran
Article information
  • International Journal of High Risk Behaviors and Addiction: June 01, 2015, 4 (2); e23751
  • Published Online: June 20, 2015
  • Article Type: Research Article
  • Received: September 19, 2014
  • Revised: December 15, 2014
  • Accepted: December 17, 2014
  • DOI: 10.5812/ijhrba.23751v2

To Cite: Shahbazi M, Farnia M, Moradi G, Karamati M, Paknazar F, et al. Injecting Drug Users Retention in Needle-Exchange Program and its Determinants in Iran Prisons, Int J High Risk Behav Addict. 2015 ;4(2):e23751. doi: 10.5812/ijhrba.23751v2.

Abstract
Copyright © 2015, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Bruneau J, Lamothe F, Franco E, Lachance N, Desy M, Soto J, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol. 1997; 146(12): 994-1002[PubMed]
  • 2. Ball A, Beg M, Doupe A, Weiler GA. Evidence for Action: A critical tool for guiding policies and programmes for HIV prevention, treatment and care among injecting drug users. Int. J. Drug Policy. 2005; 16(1): 1-6[DOI]
  • 3. Day C, Nassirimanesh B, Shakeshaft A, Dolan K. Patterns of drug use among a sample of drug users and injecting drug users attending a General Practice in Iran. Harm Reduct J. 2006; 3: 2[DOI][PubMed]
  • 4. Friedman SR, Des Jarlais DC. HIV among drug injectors: the epidemic and the response. AIDS Care. 1991; 3(3): 239-50[DOI][PubMed]
  • 5. International consultation on the criminalization of HIV transmission: 31 October-2 November 2007, Geneva, Switzerland. Joint United Nations Programme on HIV/AIDS (UNAIDS) Geneva, United Nations Development Programme (UNDP), New York, 2007. Reprod Health Matters. 2009; 17(34): 180-6[DOI][PubMed]
  • 6. Vlahov D, Junge B. The role of needle exchange programs in HIV prevention. Public Health Rep. 1998; 113 Suppl 1: 75-80[PubMed]
  • 7. Islam M, Wodak A, Conigrave KM. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings. Int J Drug Policy. 2008; 19(6): 436-41[DOI][PubMed]
  • 8. Ray Kim W. Global epidemiology and burden of hepatitis C. Microbes Infect. 2002; 4(12): 1219-25[PubMed]
  • 9. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol. 2002; 17(10): 1092-7[PubMed]
  • 10. Bluthenthal RN, Kral AH, Gee L, Erringer EA, Edlin BR. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS. 2000; 14(5): 605-11[PubMed]
  • 11. Des Jarlais DC, Hagan H, Friedman SR, Friedmann P, Goldberg D, Frischer M, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1995; 274(15): 1226-31[PubMed]
  • 12. Stöver H, Nelles J. Ten years of experience with needle and syringe exchange programmes in European prisons. Int. J. Drug Policy. 2003; 14(5-6): 437-44[DOI]
  • 13. Heimer R. Can syringe exchange serve as a conduit to substance abuse treatment? J Subst Abuse Treat. 1998; 15(3): 183-91[PubMed]
  • 14. Drucker E, Lurie P, Wodak A, Alcabes P. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS. 1998; 12 Suppl A-30[PubMed]
  • 15. MacDonald M, Law M, Kaldor J, Hales J, J. Dore G. Effectiveness of needle and syringe programmes for preventing HIV transmission. Int. J. Drug Policy. 2003; 14(5-6): 353-7[DOI]
  • 16. MacDonald M, Wodak AD, Ali R, Crofts N, Cunningham PH, Dolan KA, et al. HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges. Med J Aust. 1997; 166(5): 237-40[PubMed]
  • 17. Vicente J, Wiessing L, Emcdda NFP, expert N. European Monitoring Centre for Drugs and Drug Addiction annual report 2007: positive assessment of HIV in IDUs though hepatitis C still very high. Euro Surveill. 2007; 12(11)[PubMed]
  • 18. Nelles J, Fuhrer A, Hirsbrunner H, Harding T. Provision of syringes: the cutting edge of harm reduction in prison? BMJ. 1998; 317(7153): 270-3[PubMed]
  • 19. Gore SM, Hutchinson SJ, Cassidy J, Bird AG, Biswas S. How many drug rehabilitation places are needed in prisons to reduce the risk of bloodborne virus infection? Commun Dis Public Health. 1999; 2(3): 193-5[PubMed]
  • 20. Small D, Drucker E. Closed to reason: time for accountability for the International Narcotic Control Board. Harm Reduct J. 2007; 4: 13[PubMed]
  • 21. Jürgens R. Interventions to address HIV in prisons: Needle and syringe programmes and decontamination strategies. 2007;
  • 22. Jurgens R, Ball A, Verster A. Interventions to reduce HIV transmission related to injecting drug use in prison. Lancet Infect Dis. 2009; 9(1): 57-66[DOI][PubMed]
  • 23. Chu S. Clean switch: the case for prison needle and syringe programs. HIV AIDS Policy Law Rev. 2009; 14(2): 5-19[PubMed]
  • 24. Eskandarieh S, Jafari F, Yazdani S, Hazrati N, Saberi-Zafarghandi MB. Compulsory Maintenance Treatment Program Amongst Iranian Injection Drug Users and Its Side Effects. Int J High Risk Behav Addict. 2014; 3(4)[DOI]
  • 25. Dolan KA, Shearer J, White B, Zhou J, Kaldor J, Wodak AD. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Addiction. 2005; 100(6): 820-8[DOI][PubMed]
  • 26. Dolan K, Rutter S, Wodak AD. Prison-based syringe exchange programmes: a review of international research and development. Addiction. 2003; 98(2): 153-8[PubMed]
  • 27. Prison-Based Syringe Exchange Programs (PSE Programs). 2008;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments